Genzyme CorporationCambridge, MA, United States (NASDAQ (GS): GENZ)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Company Description

Genzyme makes big money off small-time diseases. The company's product portfolio focuses on rare genetic disorders as well as organ transplant,...

Headquarters:

500 Kendall St.
Cambridge, MA 02142
United States  (Map)

Key Genzyme Financials

Company Type Public - NASDAQ (GS): GENZ
Main Headquarters
Fiscal Year-End December
2007 Sales (mil.) $3,813.5
2007 Employees 10,000

Latest Genzyme Jobs jobs by Indeed

Rankings

  • S&P 500
  • #477 in FT Global 500

Competition

Competitive Landscape for Biotechnology Sector

Demand for biotechnology products and services is driven primarily by the willingness of insurers to pay for new medical treatments. The profitability of individual companies depends on the...

Top Genzyme Competitors

Trading Toolbox

Genzyme Executives sponsored by genius.com

Title Name & Bio Contact
Chairman, President, and CEO Henri A. Termeer Network | E-mail
EVP Finance, CFO, and Chief Accounting Officer Michael S. Wyzga Network | E-mail
SVP Corporate Development Richard H. Douglas Network | E-mail
Are You Listed On Hoover's?
Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record.
Tools from our advertising partners:
Free Web-Touch eKit Get Leads Start A Franchise

Latest Genzyme Video

  • interviewee
    Genzyme CEO on Earnings (3:31)
    10/24/07 3:31ET - Genzyme CEO Henri Termeer discusses his company's latest earnings results with CNBC's Maria Bartiromo.